Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia—Results of a phase 1/2 randomized, double-blinded, controlled trial

Authors:

Abstract
No abstract available
Funding Information
  • PATH

This publication has 34 references indexed in Scilit: